{"id":330,"date":"2022-06-22T14:32:43","date_gmt":"2022-06-22T12:32:43","guid":{"rendered":"https:\/\/tonetx.eu\/mission-and-objectives\/"},"modified":"2023-08-01T07:26:42","modified_gmt":"2023-08-01T05:26:42","slug":"mission-and-objectives","status":"publish","type":"page","link":"https:\/\/tonetx.eu\/en\/mission-and-objectives\/","title":{"rendered":"MISSION AND OBJECTIVES"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Hero section” _builder_version=”4.19.4″ _module_preset=”default” background_image=”https:\/\/tonetx.eu\/wp-content\/uploads\/2023\/02\/iStock-1250270666-scaled.jpg” background_position=”bottom_center” background_vertical_offset=”23%” custom_margin=”|||” custom_padding=”5%||5%||false|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ _module_preset=”default” custom_margin=”|||” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”1px|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_cta title=”MISSION AND OBJECTIVES” button_url=”#” _builder_version=”4.17.4″ _module_preset=”default” header_level=”h1″ header_font=”Lato|900||on|||||” header_font_size=”80px” header_letter_spacing=”2px” header_line_height=”1.2em” body_font=”Lato||||||||” body_font_size=”20px” body_line_height=”1.8em” use_background_color=”off” custom_button=”on” button_text_size=”16px” button_text_color=”#ffffff” button_bg_color=”#fa7f28″ button_border_width=”6px” button_border_color=”#fa7f28″ button_border_radius=”5px” button_letter_spacing=”2px” button_font=”Lato|900||on|||||” text_orientation=”left” max_width=”750px” module_alignment=”left” animation_style=”fold” animation_intensity_fold=”16%” header_font_size_tablet=”46px” header_font_size_phone=”” header_font_size_last_edited=”on|tablet” header_text_shadow_style=”preset1″ header_text_shadow_blur_strength=”0.6em” header_text_shadow_color=”rgba(0,0,0,0.6)” box_shadow_style_button=”preset3″ box_shadow_blur_button=”30px” box_shadow_spread_button=”8px” box_shadow_color_button=”rgba(250,127,40,0.15)” button_letter_spacing_hover=”2px” global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”2px” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_cta][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Features” _builder_version=”4.16″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 0%|#e8eefc 100%” background_color_gradient_start=”#ffffff” background_color_gradient_end=”#e8eefc” custom_padding=”100px|0px|100px|0px” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.19.4″ _module_preset=”default” background_color=”#ffffff” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||30px||false|false” custom_padding=”0px|0px|0px|0px|false|false” animation_style=”slide” animation_direction=”bottom” animation_intensity_slide=”6%” animation_starting_opacity=”100%” border_radii=”on|15px|15px|15px|15px” border_color_all=”gcid-0881eb85-6db4-495d-84c3-350d3a9274f0″ border_width_top=”18px” box_shadow_style=”preset3″ box_shadow_vertical=”39px” box_shadow_blur=”80px” box_shadow_color=”rgba(0,0,0,0.1)” custom_width_px=”1280px” locked=”off” global_colors_info=”{%22gcid-0881eb85-6db4-495d-84c3-350d3a9274f0%22:%91%22border_color_all%22%93}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”30px|40px|30px|40px” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_icon font_icon=”||fa||900″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_icon][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” text_font=”Arial||||||||” text_text_color=”#000000″ text_font_size=”15px” text_line_height=”2em” header_font=”Lato||||||||” header_2_font=”Arial||||||||” header_2_font_size=”42px” header_2_line_height=”1.5em” text_orientation=”center” max_width=”800px” module_alignment=”center” locked=”off” global_colors_info=”{}”]<\/p>\n

MISSION<\/h2>\n

Develop novel, safer and more effective therapeutic treatments to broadly fight cancer and autoimmune diseases.[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”30px|40px|30px|40px” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_icon font_icon=”||fa||900″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_icon][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” text_font=”Arial||||||||” text_text_color=”#000000″ text_font_size=”15px” text_line_height=”2em” header_font=”Lato||||||||” header_2_font=”Arial||||||||” header_2_font_size=”42px” header_2_line_height=”1.5em” text_orientation=”center” max_width=”800px” module_alignment=”center” locked=”off” global_colors_info=”{}”]<\/p>\n

OBJECTIVES<\/h2>\n

Generate new therapeutic ASO against the RNA transcribed from LINE1 repetitive elements, that can modulate the immunological response of lymphocytes infiltrating pathological tissue to fight neoplastic and autoimmune diseases.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Hero section” _builder_version=”4.19.4″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”rgba(150,105,97,0.67) 0%|rgba(2,0,76,0.84) 100%” background_color_gradient_overlays_image=”on” background_color_gradient_start=”rgba(150,105,97,0.67)” background_color_gradient_end=”rgba(2,0,76,0.84)” background_image=”https:\/\/tonetx.eu\/wp-content\/uploads\/2023\/02\/iStock-1250270666-scaled.jpg” background_position=”top_center” custom_margin=”|||” custom_padding=”10%||10%|” locked=”off” global_colors_info=”{}”][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

MISSION Develop novel, safer and more effective therapeutic treatments to broadly fight cancer and autoimmune diseases.OBJECTIVES Generate new therapeutic ASO against the RNA transcribed from LINE1 repetitive elements, that can modulate the immunological response of lymphocytes infiltrating pathological tissue to fight neoplastic and autoimmune diseases.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-330","page","type-page","status-publish","hentry"],"yoast_head":"\nMISSION AND OBJECTIVES - T-ONE Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tonetx.eu\/en\/mission-and-objectives\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MISSION AND OBJECTIVES - T-ONE Therapeutics\" \/>\n<meta property=\"og:description\" content=\"MISSION Develop novel, safer and more effective therapeutic treatments to broadly fight cancer and autoimmune diseases.OBJECTIVES Generate new therapeutic ASO against the RNA transcribed from LINE1 repetitive elements, that can modulate the immunological response of lymphocytes infiltrating pathological tissue to fight neoplastic and autoimmune diseases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tonetx.eu\/en\/mission-and-objectives\/\" \/>\n<meta property=\"og:site_name\" content=\"T-ONE Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-01T05:26:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tonetx.eu\/en\/mission-and-objectives\/\",\"url\":\"https:\/\/tonetx.eu\/en\/mission-and-objectives\/\",\"name\":\"MISSION AND OBJECTIVES - T-ONE Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/tonetx.eu\/#website\"},\"datePublished\":\"2022-06-22T12:32:43+00:00\",\"dateModified\":\"2023-08-01T05:26:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/tonetx.eu\/en\/mission-and-objectives\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tonetx.eu\/en\/mission-and-objectives\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tonetx.eu\/en\/mission-and-objectives\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tonetx.eu\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MISSION AND OBJECTIVES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tonetx.eu\/#website\",\"url\":\"https:\/\/tonetx.eu\/\",\"name\":\"T-ONE Therapeutics\",\"description\":\"Developing a novel therapeutic approach to fight cancer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tonetx.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MISSION AND OBJECTIVES - T-ONE Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tonetx.eu\/en\/mission-and-objectives\/","og_locale":"en_US","og_type":"article","og_title":"MISSION AND OBJECTIVES - T-ONE Therapeutics","og_description":"MISSION Develop novel, safer and more effective therapeutic treatments to broadly fight cancer and autoimmune diseases.OBJECTIVES Generate new therapeutic ASO against the RNA transcribed from LINE1 repetitive elements, that can modulate the immunological response of lymphocytes infiltrating pathological tissue to fight neoplastic and autoimmune diseases.","og_url":"https:\/\/tonetx.eu\/en\/mission-and-objectives\/","og_site_name":"T-ONE Therapeutics","article_modified_time":"2023-08-01T05:26:42+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tonetx.eu\/en\/mission-and-objectives\/","url":"https:\/\/tonetx.eu\/en\/mission-and-objectives\/","name":"MISSION AND OBJECTIVES - T-ONE Therapeutics","isPartOf":{"@id":"https:\/\/tonetx.eu\/#website"},"datePublished":"2022-06-22T12:32:43+00:00","dateModified":"2023-08-01T05:26:42+00:00","breadcrumb":{"@id":"https:\/\/tonetx.eu\/en\/mission-and-objectives\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tonetx.eu\/en\/mission-and-objectives\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/tonetx.eu\/en\/mission-and-objectives\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tonetx.eu\/en\/"},{"@type":"ListItem","position":2,"name":"MISSION AND OBJECTIVES"}]},{"@type":"WebSite","@id":"https:\/\/tonetx.eu\/#website","url":"https:\/\/tonetx.eu\/","name":"T-ONE Therapeutics","description":"Developing a novel therapeutic approach to fight cancer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tonetx.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/pages\/330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/comments?post=330"}],"version-history":[{"count":10,"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/pages\/330\/revisions"}],"predecessor-version":[{"id":1690,"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/pages\/330\/revisions\/1690"}],"wp:attachment":[{"href":"https:\/\/tonetx.eu\/en\/wp-json\/wp\/v2\/media?parent=330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}